A Clinical Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori Infection
A Randomized, Controlled, Double-blind Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori Infection
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Contact
Study Contact
- Name: Yang Bai
- Phone Number: 13925001665
- Email: 13925001665@163.com
Study Contact Backup
- Name: Hongying Fan
- Phone Number: 13631381172
- Email: biofhy@126.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18-75 years.
- Diagnosed by 13C-UBT within 2 weeks before entry.
Exclusion Criteria:
- Previous treatment for H. pylori infection.
- Administration of antibiotics, probiotics/prebiotics, PPIs, H2 receptor antagonists, bismuth preparations, laxatives, anti-diarrhoeals, and certain antimicrobial traditional Chinese medicines 4 weeks before.
- Previous history of gastrointestinal surgery.
- Severe or unstable diseases.
- Pregnancy or lactation.
- Alcoholics and drug abusers.
- Staff of this trial.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Lactobacillus plantarum
1.5×10^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.
|
1.5×10^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.
|
|
Experimental: Bacillus coagulans
1.5×10^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.
|
1.5×10^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.
|
|
Experimental: Lactobacillus plantarum + Bacillus coagulans
1.5×10^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.
|
1.5×10^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.
|
|
Placebo Comparator: Placebo
Adult milk powder 15 g per time, three times daily and half an hour before meal.
|
Adult milk powder 15 g pertime, three times daily and half an hour before meal.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eradication of Helicobacter pylori
Time Frame: The eighth week of the trial
|
All participants will have a 13C-urea breath test to see if their 13C value falls below the threshold for H. pylori eradication.
|
The eighth week of the trial
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The condition of gastrointestinal symptoms before the trial
Time Frame: Baseline
|
We will use Gastrointestinal symptoms rating scale (GSRS) to know about the baseline level of their gastrointestinal symptoms before they receive the probiotic or placebo.
|
Baseline
|
|
The condition of gastrointestinal symptoms in the first week
Time Frame: The first week of the trial.
|
We will use Gastrointestinal symptoms rating scale (GSRS) to know about the level of their gastrointestinal symptoms after they receive the probiotic or placebo already a week.
|
The first week of the trial.
|
|
The condition of gastrointestinal symptoms in the second week
Time Frame: The second week of the trial.
|
We will use Gastrointestinal symptoms rating scale (GSRS) to know about the level of their gastrointestinal symptoms after they receive the probiotic or placebo after two weeks.
|
The second week of the trial.
|
|
The condition of gastrointestinal symptoms in the third week
Time Frame: The third week of the trial.
|
We will use Gastrointestinal symptoms rating scale (GSRS) to know about the level of their gastrointestinal symptoms after they receive the probiotic or placebo after three weeks.
|
The third week of the trial.
|
|
The condition of gastrointestinal symptoms in the fourth week
Time Frame: The fourth week of the trial.
|
We will use Gastrointestinal symptoms rating scale (GSRS) to know about the level of their gastrointestinal symptoms at the fourth week of this trial.
|
The fourth week of the trial.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NFEC-2022-252
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.